nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—hypertension—obesity	0.747	1	CtDrD
Olmesartan—ABCC2—bile—obesity	0.00518	0.286	CbGeAlD
Olmesartan—SLCO1B3—pituitary gland—obesity	0.00138	0.076	CbGeAlD
Olmesartan—SLCO1B3—endocrine gland—obesity	0.00107	0.0589	CbGeAlD
Olmesartan—AGTR1—adrenal cortex—obesity	0.00103	0.057	CbGeAlD
Olmesartan—SLCO1B3—liver—obesity	0.000962	0.0531	CbGeAlD
Olmesartan—AGTR1—cardiovascular system—obesity	0.000943	0.052	CbGeAlD
Olmesartan—AGTR1—pituitary gland—obesity	0.000835	0.0461	CbGeAlD
Olmesartan—AGTR1—adipose tissue—obesity	0.000832	0.0459	CbGeAlD
Olmesartan—SLCO1B1—digestive system—obesity	0.000746	0.0412	CbGeAlD
Olmesartan—AGTR1—adrenal gland—obesity	0.000746	0.0412	CbGeAlD
Olmesartan—AGTR1—endocrine gland—obesity	0.000647	0.0357	CbGeAlD
Olmesartan—SLCO1B1—endocrine gland—obesity	0.000617	0.034	CbGeAlD
Olmesartan—AGTR1—liver—obesity	0.000583	0.0322	CbGeAlD
Olmesartan—ABCC2—digestive system—obesity	0.000566	0.0312	CbGeAlD
Olmesartan—Telmisartan—PPARG—obesity	0.00056	0.483	CrCbGaD
Olmesartan—SLCO1B1—liver—obesity	0.000556	0.0307	CbGeAlD
Olmesartan—ABCC2—adrenal gland—obesity	0.000539	0.0298	CbGeAlD
Olmesartan—ABCC2—endocrine gland—obesity	0.000468	0.0258	CbGeAlD
Olmesartan—ABCC2—liver—obesity	0.000422	0.0233	CbGeAlD
Olmesartan—Losartan—ACE—obesity	0.000267	0.23	CrCbGaD
Olmesartan—Valsartan—ALB—obesity	0.000224	0.193	CrCbGaD
Olmesartan—Muscle spasms—Orlistat—obesity	0.000207	0.00146	CcSEcCtD
Olmesartan—Urinary tract disorder—Bupropion—obesity	0.000206	0.00146	CcSEcCtD
Olmesartan—Oedema peripheral—Bupropion—obesity	0.000205	0.00145	CcSEcCtD
Olmesartan—Connective tissue disorder—Bupropion—obesity	0.000205	0.00145	CcSEcCtD
Olmesartan—Urethral disorder—Bupropion—obesity	0.000204	0.00145	CcSEcCtD
Olmesartan—Vision blurred—Orlistat—obesity	0.000203	0.00144	CcSEcCtD
Olmesartan—Vomiting—Cimetidine—obesity	0.000202	0.00143	CcSEcCtD
Olmesartan—Back pain—Sibutramine—obesity	0.000201	0.00143	CcSEcCtD
Olmesartan—Rash—Cimetidine—obesity	0.0002	0.00142	CcSEcCtD
Olmesartan—Dermatitis—Cimetidine—obesity	0.0002	0.00142	CcSEcCtD
Olmesartan—Muscle spasms—Sibutramine—obesity	0.0002	0.00142	CcSEcCtD
Olmesartan—Ill-defined disorder—Orlistat—obesity	0.000199	0.00141	CcSEcCtD
Olmesartan—Headache—Cimetidine—obesity	0.000199	0.00141	CcSEcCtD
Olmesartan—Nausea—Diethylpropion—obesity	0.000198	0.00141	CcSEcCtD
Olmesartan—Angioedema—Orlistat—obesity	0.000196	0.00139	CcSEcCtD
Olmesartan—Vision blurred—Sibutramine—obesity	0.000196	0.00139	CcSEcCtD
Olmesartan—Lethargy—Topiramate—obesity	0.000196	0.00139	CcSEcCtD
Olmesartan—Malaise—Orlistat—obesity	0.000194	0.00137	CcSEcCtD
Olmesartan—Vertigo—Orlistat—obesity	0.000193	0.00137	CcSEcCtD
Olmesartan—Ill-defined disorder—Sibutramine—obesity	0.000193	0.00137	CcSEcCtD
Olmesartan—Hyponatraemia—Topiramate—obesity	0.000193	0.00137	CcSEcCtD
Olmesartan—Anaemia—Sibutramine—obesity	0.000192	0.00136	CcSEcCtD
Olmesartan—Pain in extremity—Topiramate—obesity	0.000192	0.00136	CcSEcCtD
Olmesartan—Agitation—Sibutramine—obesity	0.000191	0.00135	CcSEcCtD
Olmesartan—Angioedema—Sibutramine—obesity	0.00019	0.00135	CcSEcCtD
Olmesartan—Palpitations—Orlistat—obesity	0.00019	0.00135	CcSEcCtD
Olmesartan—Angiopathy—Bupropion—obesity	0.000189	0.00134	CcSEcCtD
Olmesartan—Nausea—Cimetidine—obesity	0.000189	0.00134	CcSEcCtD
Olmesartan—Mediastinal disorder—Bupropion—obesity	0.000188	0.00133	CcSEcCtD
Olmesartan—Malaise—Sibutramine—obesity	0.000188	0.00133	CcSEcCtD
Olmesartan—Cough—Orlistat—obesity	0.000188	0.00133	CcSEcCtD
Olmesartan—Vertigo—Sibutramine—obesity	0.000187	0.00132	CcSEcCtD
Olmesartan—Syncope—Sibutramine—obesity	0.000187	0.00132	CcSEcCtD
Olmesartan—Leukopenia—Sibutramine—obesity	0.000186	0.00132	CcSEcCtD
Olmesartan—Arrhythmia—Bupropion—obesity	0.000186	0.00132	CcSEcCtD
Olmesartan—Face oedema—Topiramate—obesity	0.000185	0.00131	CcSEcCtD
Olmesartan—Alopecia—Bupropion—obesity	0.000184	0.0013	CcSEcCtD
Olmesartan—Palpitations—Sibutramine—obesity	0.000184	0.0013	CcSEcCtD
Olmesartan—Chest pain—Orlistat—obesity	0.000183	0.0013	CcSEcCtD
Olmesartan—Myalgia—Orlistat—obesity	0.000183	0.0013	CcSEcCtD
Olmesartan—Loss of consciousness—Sibutramine—obesity	0.000183	0.0013	CcSEcCtD
Olmesartan—Mental disorder—Bupropion—obesity	0.000183	0.00129	CcSEcCtD
Olmesartan—Anxiety—Orlistat—obesity	0.000182	0.00129	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000182	0.00129	CcSEcCtD
Olmesartan—Cough—Sibutramine—obesity	0.000182	0.00129	CcSEcCtD
Olmesartan—Malnutrition—Bupropion—obesity	0.000181	0.00129	CcSEcCtD
Olmesartan—Discomfort—Orlistat—obesity	0.000181	0.00128	CcSEcCtD
Olmesartan—Blood creatinine increased—Topiramate—obesity	0.00018	0.00127	CcSEcCtD
Olmesartan—Arthralgia—Sibutramine—obesity	0.000177	0.00126	CcSEcCtD
Olmesartan—Chest pain—Sibutramine—obesity	0.000177	0.00126	CcSEcCtD
Olmesartan—Myalgia—Sibutramine—obesity	0.000177	0.00126	CcSEcCtD
Olmesartan—Anxiety—Sibutramine—obesity	0.000177	0.00125	CcSEcCtD
Olmesartan—Oedema—Orlistat—obesity	0.000175	0.00124	CcSEcCtD
Olmesartan—Anaphylactic shock—Orlistat—obesity	0.000175	0.00124	CcSEcCtD
Olmesartan—Back pain—Bupropion—obesity	0.000175	0.00124	CcSEcCtD
Olmesartan—Orthostatic hypotension—Topiramate—obesity	0.000175	0.00124	CcSEcCtD
Olmesartan—Discomfort—Sibutramine—obesity	0.000175	0.00124	CcSEcCtD
Olmesartan—Hypokalaemia—Topiramate—obesity	0.000175	0.00124	CcSEcCtD
Olmesartan—Muscle spasms—Bupropion—obesity	0.000174	0.00124	CcSEcCtD
Olmesartan—Infection—Orlistat—obesity	0.000174	0.00124	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Topiramate—obesity	0.000173	0.00122	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Topiramate—obesity	0.000173	0.00122	CcSEcCtD
Olmesartan—Nervous system disorder—Orlistat—obesity	0.000172	0.00122	CcSEcCtD
Olmesartan—Nasopharyngitis—Topiramate—obesity	0.000172	0.00122	CcSEcCtD
Olmesartan—Vision blurred—Bupropion—obesity	0.000171	0.00121	CcSEcCtD
Olmesartan—Skin disorder—Orlistat—obesity	0.00017	0.00121	CcSEcCtD
Olmesartan—Anaphylactic shock—Sibutramine—obesity	0.00017	0.0012	CcSEcCtD
Olmesartan—Oedema—Sibutramine—obesity	0.00017	0.0012	CcSEcCtD
Olmesartan—Hyperhidrosis—Orlistat—obesity	0.00017	0.0012	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Topiramate—obesity	0.000169	0.0012	CcSEcCtD
Olmesartan—Infection—Sibutramine—obesity	0.000169	0.0012	CcSEcCtD
Olmesartan—Ill-defined disorder—Bupropion—obesity	0.000168	0.00119	CcSEcCtD
Olmesartan—Anaemia—Bupropion—obesity	0.000168	0.00119	CcSEcCtD
Olmesartan—Shock—Sibutramine—obesity	0.000167	0.00118	CcSEcCtD
Olmesartan—Agitation—Bupropion—obesity	0.000167	0.00118	CcSEcCtD
Olmesartan—Thrombocytopenia—Sibutramine—obesity	0.000166	0.00118	CcSEcCtD
Olmesartan—Angioedema—Bupropion—obesity	0.000166	0.00117	CcSEcCtD
Olmesartan—Tachycardia—Sibutramine—obesity	0.000166	0.00117	CcSEcCtD
Olmesartan—Skin disorder—Sibutramine—obesity	0.000165	0.00117	CcSEcCtD
Olmesartan—Eosinophilia—Topiramate—obesity	0.000164	0.00116	CcSEcCtD
Olmesartan—Hyperhidrosis—Sibutramine—obesity	0.000164	0.00116	CcSEcCtD
Olmesartan—Malaise—Bupropion—obesity	0.000164	0.00116	CcSEcCtD
Olmesartan—Vertigo—Bupropion—obesity	0.000163	0.00115	CcSEcCtD
Olmesartan—Syncope—Bupropion—obesity	0.000163	0.00115	CcSEcCtD
Olmesartan—Pancreatitis—Topiramate—obesity	0.000163	0.00115	CcSEcCtD
Olmesartan—Leukopenia—Bupropion—obesity	0.000162	0.00115	CcSEcCtD
Olmesartan—Anorexia—Sibutramine—obesity	0.000162	0.00115	CcSEcCtD
Olmesartan—Angina pectoris—Topiramate—obesity	0.000162	0.00114	CcSEcCtD
Olmesartan—Palpitations—Bupropion—obesity	0.00016	0.00114	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Orlistat—obesity	0.00016	0.00113	CcSEcCtD
Olmesartan—Bronchitis—Topiramate—obesity	0.00016	0.00113	CcSEcCtD
Olmesartan—Loss of consciousness—Bupropion—obesity	0.000159	0.00113	CcSEcCtD
Olmesartan—Insomnia—Orlistat—obesity	0.000159	0.00112	CcSEcCtD
Olmesartan—Hypotension—Sibutramine—obesity	0.000159	0.00112	CcSEcCtD
Olmesartan—Cough—Bupropion—obesity	0.000158	0.00112	CcSEcCtD
Olmesartan—Pancytopenia—Topiramate—obesity	0.000158	0.00112	CcSEcCtD
Olmesartan—Neutropenia—Topiramate—obesity	0.000155	0.0011	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Sibutramine—obesity	0.000155	0.0011	CcSEcCtD
Olmesartan—Dyspepsia—Orlistat—obesity	0.000154	0.00109	CcSEcCtD
Olmesartan—Chest pain—Bupropion—obesity	0.000154	0.00109	CcSEcCtD
Olmesartan—Myalgia—Bupropion—obesity	0.000154	0.00109	CcSEcCtD
Olmesartan—Arthralgia—Bupropion—obesity	0.000154	0.00109	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Topiramate—obesity	0.000154	0.00109	CcSEcCtD
Olmesartan—Anxiety—Bupropion—obesity	0.000154	0.00109	CcSEcCtD
Olmesartan—Insomnia—Sibutramine—obesity	0.000154	0.00109	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000153	0.00109	CcSEcCtD
Olmesartan—Erectile dysfunction—Topiramate—obesity	0.000153	0.00108	CcSEcCtD
Olmesartan—Discomfort—Bupropion—obesity	0.000153	0.00108	CcSEcCtD
Olmesartan—Decreased appetite—Orlistat—obesity	0.000153	0.00108	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Orlistat—obesity	0.000151	0.00107	CcSEcCtD
Olmesartan—Photosensitivity reaction—Topiramate—obesity	0.000151	0.00107	CcSEcCtD
Olmesartan—Fatigue—Orlistat—obesity	0.000151	0.00107	CcSEcCtD
Olmesartan—Pain—Orlistat—obesity	0.00015	0.00106	CcSEcCtD
Olmesartan—Hyperglycaemia—Topiramate—obesity	0.00015	0.00106	CcSEcCtD
Olmesartan—Dyspepsia—Sibutramine—obesity	0.000149	0.00106	CcSEcCtD
Olmesartan—Pneumonia—Topiramate—obesity	0.000149	0.00105	CcSEcCtD
Olmesartan—Anaphylactic shock—Bupropion—obesity	0.000148	0.00105	CcSEcCtD
Olmesartan—Oedema—Bupropion—obesity	0.000148	0.00105	CcSEcCtD
Olmesartan—Infestation NOS—Topiramate—obesity	0.000148	0.00105	CcSEcCtD
Olmesartan—Infestation—Topiramate—obesity	0.000148	0.00105	CcSEcCtD
Olmesartan—Decreased appetite—Sibutramine—obesity	0.000148	0.00105	CcSEcCtD
Olmesartan—Infection—Bupropion—obesity	0.000147	0.00104	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Sibutramine—obesity	0.000147	0.00104	CcSEcCtD
Olmesartan—Shock—Bupropion—obesity	0.000146	0.00103	CcSEcCtD
Olmesartan—Renal failure—Topiramate—obesity	0.000145	0.00103	CcSEcCtD
Olmesartan—Pain—Sibutramine—obesity	0.000145	0.00103	CcSEcCtD
Olmesartan—Constipation—Sibutramine—obesity	0.000145	0.00103	CcSEcCtD
Olmesartan—Nervous system disorder—Bupropion—obesity	0.000145	0.00103	CcSEcCtD
Olmesartan—Thrombocytopenia—Bupropion—obesity	0.000145	0.00103	CcSEcCtD
Olmesartan—Feeling abnormal—Orlistat—obesity	0.000145	0.00102	CcSEcCtD
Olmesartan—Tachycardia—Bupropion—obesity	0.000144	0.00102	CcSEcCtD
Olmesartan—Skin disorder—Bupropion—obesity	0.000144	0.00102	CcSEcCtD
Olmesartan—Urinary tract infection—Topiramate—obesity	0.000144	0.00102	CcSEcCtD
Olmesartan—Gastrointestinal pain—Orlistat—obesity	0.000143	0.00102	CcSEcCtD
Olmesartan—Hyperhidrosis—Bupropion—obesity	0.000143	0.00101	CcSEcCtD
Olmesartan—Anorexia—Bupropion—obesity	0.000141	0.001	CcSEcCtD
Olmesartan—Haematuria—Topiramate—obesity	0.000141	0.000999	CcSEcCtD
Olmesartan—Feeling abnormal—Sibutramine—obesity	0.00014	0.000991	CcSEcCtD
Olmesartan—Urticaria—Orlistat—obesity	0.000139	0.000988	CcSEcCtD
Olmesartan—Gastrointestinal pain—Sibutramine—obesity	0.000139	0.000984	CcSEcCtD
Olmesartan—Sinusitis—Topiramate—obesity	0.000139	0.000983	CcSEcCtD
Olmesartan—Abdominal pain—Orlistat—obesity	0.000139	0.000983	CcSEcCtD
Olmesartan—Body temperature increased—Orlistat—obesity	0.000139	0.000983	CcSEcCtD
Olmesartan—Hypotension—Bupropion—obesity	0.000138	0.00098	CcSEcCtD
Olmesartan—Agranulocytosis—Topiramate—obesity	0.000138	0.000978	CcSEcCtD
Olmesartan—Urticaria—Sibutramine—obesity	0.000135	0.000956	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Bupropion—obesity	0.000135	0.000956	CcSEcCtD
Olmesartan—Body temperature increased—Sibutramine—obesity	0.000134	0.000951	CcSEcCtD
Olmesartan—Abdominal pain—Sibutramine—obesity	0.000134	0.000951	CcSEcCtD
Olmesartan—Insomnia—Bupropion—obesity	0.000134	0.000949	CcSEcCtD
Olmesartan—Rhinitis—Topiramate—obesity	0.000133	0.000943	CcSEcCtD
Olmesartan—Pharyngitis—Topiramate—obesity	0.000132	0.000934	CcSEcCtD
Olmesartan—Urinary tract disorder—Topiramate—obesity	0.000131	0.000929	CcSEcCtD
Olmesartan—Oedema peripheral—Topiramate—obesity	0.000131	0.000927	CcSEcCtD
Olmesartan—Connective tissue disorder—Topiramate—obesity	0.00013	0.000924	CcSEcCtD
Olmesartan—Dyspepsia—Bupropion—obesity	0.00013	0.000923	CcSEcCtD
Olmesartan—Urethral disorder—Topiramate—obesity	0.00013	0.000922	CcSEcCtD
Olmesartan—Decreased appetite—Bupropion—obesity	0.000129	0.000912	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Bupropion—obesity	0.000128	0.000906	CcSEcCtD
Olmesartan—Fatigue—Bupropion—obesity	0.000128	0.000904	CcSEcCtD
Olmesartan—Constipation—Bupropion—obesity	0.000127	0.000897	CcSEcCtD
Olmesartan—Pain—Bupropion—obesity	0.000127	0.000897	CcSEcCtD
Olmesartan—Asthenia—Orlistat—obesity	0.000126	0.000892	CcSEcCtD
Olmesartan—Pruritus—Orlistat—obesity	0.000124	0.00088	CcSEcCtD
Olmesartan—Feeling abnormal—Bupropion—obesity	0.000122	0.000864	CcSEcCtD
Olmesartan—Asthenia—Sibutramine—obesity	0.000122	0.000863	CcSEcCtD
Olmesartan—Gastrointestinal pain—Bupropion—obesity	0.000121	0.000858	CcSEcCtD
Olmesartan—Angiopathy—Topiramate—obesity	0.00012	0.000853	CcSEcCtD
Olmesartan—Pruritus—Sibutramine—obesity	0.00012	0.000851	CcSEcCtD
Olmesartan—Diarrhoea—Orlistat—obesity	0.00012	0.000851	CcSEcCtD
Olmesartan—Mediastinal disorder—Topiramate—obesity	0.00012	0.000848	CcSEcCtD
Olmesartan—Urticaria—Bupropion—obesity	0.000118	0.000833	CcSEcCtD
Olmesartan—Alopecia—Topiramate—obesity	0.000117	0.000831	CcSEcCtD
Olmesartan—Body temperature increased—Bupropion—obesity	0.000117	0.000829	CcSEcCtD
Olmesartan—Abdominal pain—Bupropion—obesity	0.000117	0.000829	CcSEcCtD
Olmesartan—Mental disorder—Topiramate—obesity	0.000116	0.000824	CcSEcCtD
Olmesartan—Diarrhoea—Sibutramine—obesity	0.000116	0.000823	CcSEcCtD
Olmesartan—Dizziness—Orlistat—obesity	0.000116	0.000822	CcSEcCtD
Olmesartan—Malnutrition—Topiramate—obesity	0.000116	0.000819	CcSEcCtD
Olmesartan—Dizziness—Sibutramine—obesity	0.000112	0.000796	CcSEcCtD
Olmesartan—Back pain—Topiramate—obesity	0.000112	0.000792	CcSEcCtD
Olmesartan—Vomiting—Orlistat—obesity	0.000112	0.00079	CcSEcCtD
Olmesartan—Muscle spasms—Topiramate—obesity	0.000111	0.000787	CcSEcCtD
Olmesartan—Rash—Orlistat—obesity	0.000111	0.000784	CcSEcCtD
Olmesartan—Dermatitis—Orlistat—obesity	0.000111	0.000783	CcSEcCtD
Olmesartan—Headache—Orlistat—obesity	0.00011	0.000779	CcSEcCtD
Olmesartan—Losartan—ALB—obesity	0.000109	0.0943	CrCbGaD
Olmesartan—Vision blurred—Topiramate—obesity	0.000109	0.000772	CcSEcCtD
Olmesartan—Vomiting—Sibutramine—obesity	0.000108	0.000765	CcSEcCtD
Olmesartan—Ill-defined disorder—Topiramate—obesity	0.000107	0.00076	CcSEcCtD
Olmesartan—Rash—Sibutramine—obesity	0.000107	0.000759	CcSEcCtD
Olmesartan—Dermatitis—Sibutramine—obesity	0.000107	0.000758	CcSEcCtD
Olmesartan—Anaemia—Topiramate—obesity	0.000107	0.000757	CcSEcCtD
Olmesartan—Headache—Sibutramine—obesity	0.000106	0.000754	CcSEcCtD
Olmesartan—Asthenia—Bupropion—obesity	0.000106	0.000753	CcSEcCtD
Olmesartan—Agitation—Topiramate—obesity	0.000106	0.000752	CcSEcCtD
Olmesartan—Pruritus—Bupropion—obesity	0.000105	0.000742	CcSEcCtD
Olmesartan—Nausea—Orlistat—obesity	0.000104	0.000738	CcSEcCtD
Olmesartan—Malaise—Topiramate—obesity	0.000104	0.000738	CcSEcCtD
Olmesartan—Vertigo—Topiramate—obesity	0.000104	0.000736	CcSEcCtD
Olmesartan—Syncope—Topiramate—obesity	0.000104	0.000734	CcSEcCtD
Olmesartan—Leukopenia—Topiramate—obesity	0.000103	0.000733	CcSEcCtD
Olmesartan—Palpitations—Topiramate—obesity	0.000102	0.000724	CcSEcCtD
Olmesartan—Loss of consciousness—Topiramate—obesity	0.000102	0.00072	CcSEcCtD
Olmesartan—Diarrhoea—Bupropion—obesity	0.000101	0.000718	CcSEcCtD
Olmesartan—Nausea—Sibutramine—obesity	0.000101	0.000715	CcSEcCtD
Olmesartan—Cough—Topiramate—obesity	0.000101	0.000715	CcSEcCtD
Olmesartan—Chest pain—Topiramate—obesity	9.84e-05	0.000697	CcSEcCtD
Olmesartan—Arthralgia—Topiramate—obesity	9.84e-05	0.000697	CcSEcCtD
Olmesartan—Myalgia—Topiramate—obesity	9.84e-05	0.000697	CcSEcCtD
Olmesartan—Anxiety—Topiramate—obesity	9.81e-05	0.000695	CcSEcCtD
Olmesartan—Dizziness—Bupropion—obesity	9.79e-05	0.000694	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	9.77e-05	0.000692	CcSEcCtD
Olmesartan—Discomfort—Topiramate—obesity	9.72e-05	0.000689	CcSEcCtD
Olmesartan—Oedema—Topiramate—obesity	9.43e-05	0.000668	CcSEcCtD
Olmesartan—Vomiting—Bupropion—obesity	9.41e-05	0.000667	CcSEcCtD
Olmesartan—Infection—Topiramate—obesity	9.37e-05	0.000664	CcSEcCtD
Olmesartan—Rash—Bupropion—obesity	9.33e-05	0.000661	CcSEcCtD
Olmesartan—Dermatitis—Bupropion—obesity	9.33e-05	0.000661	CcSEcCtD
Olmesartan—Shock—Topiramate—obesity	9.28e-05	0.000657	CcSEcCtD
Olmesartan—Headache—Bupropion—obesity	9.27e-05	0.000657	CcSEcCtD
Olmesartan—Nervous system disorder—Topiramate—obesity	9.25e-05	0.000655	CcSEcCtD
Olmesartan—Thrombocytopenia—Topiramate—obesity	9.23e-05	0.000654	CcSEcCtD
Olmesartan—Tachycardia—Topiramate—obesity	9.21e-05	0.000652	CcSEcCtD
Olmesartan—Skin disorder—Topiramate—obesity	9.16e-05	0.000649	CcSEcCtD
Olmesartan—Hyperhidrosis—Topiramate—obesity	9.12e-05	0.000646	CcSEcCtD
Olmesartan—Anorexia—Topiramate—obesity	8.99e-05	0.000637	CcSEcCtD
Olmesartan—Hypotension—Topiramate—obesity	8.81e-05	0.000624	CcSEcCtD
Olmesartan—Nausea—Bupropion—obesity	8.79e-05	0.000623	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Topiramate—obesity	8.59e-05	0.000609	CcSEcCtD
Olmesartan—Insomnia—Topiramate—obesity	8.53e-05	0.000604	CcSEcCtD
Olmesartan—Dyspepsia—Topiramate—obesity	8.3e-05	0.000588	CcSEcCtD
Olmesartan—Decreased appetite—Topiramate—obesity	8.2e-05	0.000581	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Topiramate—obesity	8.14e-05	0.000577	CcSEcCtD
Olmesartan—Fatigue—Topiramate—obesity	8.13e-05	0.000576	CcSEcCtD
Olmesartan—Pain—Topiramate—obesity	8.07e-05	0.000571	CcSEcCtD
Olmesartan—Constipation—Topiramate—obesity	8.07e-05	0.000571	CcSEcCtD
Olmesartan—Feeling abnormal—Topiramate—obesity	7.77e-05	0.000551	CcSEcCtD
Olmesartan—Gastrointestinal pain—Topiramate—obesity	7.71e-05	0.000546	CcSEcCtD
Olmesartan—Urticaria—Topiramate—obesity	7.49e-05	0.000531	CcSEcCtD
Olmesartan—Abdominal pain—Topiramate—obesity	7.46e-05	0.000528	CcSEcCtD
Olmesartan—Body temperature increased—Topiramate—obesity	7.46e-05	0.000528	CcSEcCtD
Olmesartan—Asthenia—Topiramate—obesity	6.77e-05	0.000479	CcSEcCtD
Olmesartan—Pruritus—Topiramate—obesity	6.67e-05	0.000473	CcSEcCtD
Olmesartan—Diarrhoea—Topiramate—obesity	6.45e-05	0.000457	CcSEcCtD
Olmesartan—Dizziness—Topiramate—obesity	6.24e-05	0.000442	CcSEcCtD
Olmesartan—Vomiting—Topiramate—obesity	6e-05	0.000425	CcSEcCtD
Olmesartan—Rash—Topiramate—obesity	5.95e-05	0.000421	CcSEcCtD
Olmesartan—Dermatitis—Topiramate—obesity	5.94e-05	0.000421	CcSEcCtD
Olmesartan—Headache—Topiramate—obesity	5.91e-05	0.000419	CcSEcCtD
Olmesartan—Nausea—Topiramate—obesity	5.6e-05	0.000397	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—obesity	2.19e-05	0.000237	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACSL1—obesity	2.19e-05	0.000237	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPAM—obesity	2.19e-05	0.000237	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARGC1B—obesity	2.19e-05	0.000237	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—GNB3—obesity	2.18e-05	0.000236	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPY—obesity	2.18e-05	0.000235	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—obesity	2.17e-05	0.000235	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SDC1—obesity	2.17e-05	0.000234	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IAPP—obesity	2.16e-05	0.000234	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOC3—obesity	2.16e-05	0.000234	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKR1C3—obesity	2.13e-05	0.000231	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—GNAS—obesity	2.13e-05	0.00023	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PCK1—obesity	2.12e-05	0.00023	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—FADS1—obesity	2.12e-05	0.00023	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HADH—obesity	2.12e-05	0.00023	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AGT—obesity	2.12e-05	0.000229	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR1B—obesity	2.1e-05	0.000227	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CRH—obesity	2.1e-05	0.000227	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SCARB1—obesity	2.1e-05	0.000227	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—obesity	2.09e-05	0.000226	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOB—obesity	2.08e-05	0.000225	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SDC1—obesity	2.08e-05	0.000225	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCD—obesity	2.07e-05	0.000224	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.07e-05	0.000224	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACP5—obesity	2.07e-05	0.000224	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—obesity	2.04e-05	0.000221	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKR1C3—obesity	2.04e-05	0.000221	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—obesity	2.04e-05	0.000221	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SREBF1—obesity	2.04e-05	0.00022	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR2A—obesity	2.03e-05	0.000219	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—C3—obesity	2.02e-05	0.000219	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—G6PD—obesity	2.01e-05	0.000218	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPS—obesity	1.99e-05	0.000215	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HK1—obesity	1.99e-05	0.000215	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SREBF2—obesity	1.99e-05	0.000215	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—obesity	1.99e-05	0.000215	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GOT2—obesity	1.98e-05	0.000214	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—F2—obesity	1.96e-05	0.000212	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PRKCB—obesity	1.96e-05	0.000212	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.95e-05	0.000211	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2C—obesity	1.95e-05	0.000211	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DRD1—obesity	1.95e-05	0.000211	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—obesity	1.94e-05	0.00021	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—FASN—obesity	1.94e-05	0.00021	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—BCHE—obesity	1.93e-05	0.000209	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AGT—obesity	1.92e-05	0.000208	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPA—obesity	1.92e-05	0.000208	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NTRK2—obesity	1.9e-05	0.000205	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB1—obesity	1.89e-05	0.000205	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPIN1—obesity	1.88e-05	0.000203	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CG—obesity	1.87e-05	0.000203	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PPARA—obesity	1.87e-05	0.000202	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2E1—obesity	1.86e-05	0.000202	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GHRL—obesity	1.85e-05	0.0002	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PARP1—obesity	1.85e-05	0.0002	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—obesity	1.85e-05	0.0002	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NQO1—obesity	1.84e-05	0.000199	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA5—obesity	1.84e-05	0.000199	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DRD4—obesity	1.84e-05	0.000199	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.8e-05	0.000195	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—obesity	1.79e-05	0.000194	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.79e-05	0.000193	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—POMC—obesity	1.78e-05	0.000193	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCB—obesity	1.78e-05	0.000192	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—F2—obesity	1.78e-05	0.000192	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GCG—obesity	1.77e-05	0.000191	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC2A4—obesity	1.77e-05	0.000191	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CLOCK—obesity	1.76e-05	0.00019	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC22A1—obesity	1.76e-05	0.00019	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PPARA—obesity	1.76e-05	0.00019	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOA1—obesity	1.75e-05	0.00019	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—obesity	1.75e-05	0.00019	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CNR1—obesity	1.75e-05	0.00019	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYCS—obesity	1.74e-05	0.000189	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—obesity	1.74e-05	0.000188	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—obesity	1.73e-05	0.000187	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TCF7L2—obesity	1.72e-05	0.000186	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT2—obesity	1.71e-05	0.000185	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SULT2A1—obesity	1.71e-05	0.000185	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GLP1R—obesity	1.71e-05	0.000185	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GGT1—obesity	1.71e-05	0.000185	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GOT1—obesity	1.71e-05	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DRD2—obesity	1.71e-05	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CG—obesity	1.7e-05	0.000184	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTPN1—obesity	1.69e-05	0.000183	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GCG—obesity	1.69e-05	0.000183	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NCOA1—obesity	1.69e-05	0.000182	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—DPYD—obesity	1.68e-05	0.000182	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—STK11—obesity	1.66e-05	0.00018	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP19A1—obesity	1.66e-05	0.00018	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOA1—obesity	1.65e-05	0.000178	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CD—obesity	1.65e-05	0.000178	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PRKAR2B—obesity	1.62e-05	0.000175	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—POMC—obesity	1.62e-05	0.000175	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRL—obesity	1.61e-05	0.000175	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—DCN—obesity	1.61e-05	0.000174	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STK11—obesity	1.59e-05	0.000172	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL2—obesity	1.58e-05	0.000171	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—obesity	1.58e-05	0.000171	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLG—obesity	1.57e-05	0.00017	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—RHOA—obesity	1.57e-05	0.00017	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CPT1A—obesity	1.57e-05	0.000169	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT2—obesity	1.56e-05	0.000168	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3R1—obesity	1.56e-05	0.000168	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—COMT—obesity	1.54e-05	0.000167	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FOXO3—obesity	1.54e-05	0.000166	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NAMPT—obesity	1.54e-05	0.000166	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB2—obesity	1.53e-05	0.000166	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—obesity	1.53e-05	0.000165	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LIPC—obesity	1.53e-05	0.000165	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GCK—obesity	1.53e-05	0.000165	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GNB3—obesity	1.52e-05	0.000165	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARGC1A—obesity	1.52e-05	0.000165	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOC3—obesity	1.52e-05	0.000164	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMOX1—obesity	1.52e-05	0.000164	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SOCS1—obesity	1.51e-05	0.000163	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—obesity	1.51e-05	0.000163	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CD—obesity	1.5e-05	0.000162	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SOCS3—obesity	1.49e-05	0.000161	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GNAS—obesity	1.48e-05	0.00016	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CETP—obesity	1.47e-05	0.000159	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GNB3—obesity	1.46e-05	0.000158	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SDC1—obesity	1.46e-05	0.000158	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOB—obesity	1.45e-05	0.000157	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TYK2—obesity	1.44e-05	0.000156	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CB—obesity	1.44e-05	0.000155	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF2—obesity	1.43e-05	0.000155	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKR1C3—obesity	1.43e-05	0.000155	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RHOA—obesity	1.43e-05	0.000154	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GNAS—obesity	1.42e-05	0.000154	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3R1—obesity	1.41e-05	0.000153	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SCARB1—obesity	1.41e-05	0.000153	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOB—obesity	1.39e-05	0.000151	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.39e-05	0.00015	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—obesity	1.39e-05	0.00015	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LPL—obesity	1.39e-05	0.00015	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—obesity	1.37e-05	0.000149	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SREBF1—obesity	1.37e-05	0.000148	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL5—obesity	1.36e-05	0.000147	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GPX1—obesity	1.35e-05	0.000146	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GOT2—obesity	1.33e-05	0.000144	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LPL—obesity	1.33e-05	0.000144	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FOXO1—obesity	1.32e-05	0.000143	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CD36—obesity	1.32e-05	0.000142	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RPS6KB1—obesity	1.32e-05	0.000142	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.31e-05	0.000142	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—obesity	1.31e-05	0.000141	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CB—obesity	1.3e-05	0.000141	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—FASN—obesity	1.3e-05	0.000141	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—BCHE—obesity	1.3e-05	0.00014	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2E1—obesity	1.25e-05	0.000135	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—obesity	1.25e-05	0.000135	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NQO1—obesity	1.24e-05	0.000134	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARA—obesity	1.22e-05	0.000132	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCD—obesity	1.22e-05	0.000132	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.21e-05	0.000131	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.2e-05	0.00013	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2A—obesity	1.2e-05	0.00013	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—C3—obesity	1.2e-05	0.000129	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GCG—obesity	1.19e-05	0.000128	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC2A4—obesity	1.19e-05	0.000128	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AGT—obesity	1.19e-05	0.000128	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYCS—obesity	1.17e-05	0.000127	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOE—obesity	1.16e-05	0.000126	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAV1—obesity	1.15e-05	0.000125	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GGT1—obesity	1.15e-05	0.000124	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GOT1—obesity	1.15e-05	0.000124	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOA1—obesity	1.15e-05	0.000124	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IRS2—obesity	1.14e-05	0.000123	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AGT—obesity	1.14e-05	0.000123	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOA1—obesity	1.13e-05	0.000122	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP19A1—obesity	1.12e-05	0.000121	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—STK11—obesity	1.12e-05	0.000121	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LEP—obesity	1.11e-05	0.00012	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOE—obesity	1.11e-05	0.00012	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CAV1—obesity	1.1e-05	0.000119	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOA1—obesity	1.1e-05	0.000119	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.1e-05	0.000119	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ESR1—obesity	1.06e-05	0.000115	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2—obesity	1.05e-05	0.000114	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCB—obesity	1.05e-05	0.000114	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CG—obesity	1.05e-05	0.000113	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BAD—obesity	1.04e-05	0.000112	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—COMT—obesity	1.04e-05	0.000112	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARGC1A—obesity	1.02e-05	0.000111	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GNB3—obesity	1.02e-05	0.000111	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMOX1—obesity	1.02e-05	0.00011	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARG—obesity	1.01e-05	0.000109	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CG—obesity	1e-05	0.000109	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—POMC—obesity	9.98e-06	0.000108	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GNAS—obesity	9.96e-06	0.000108	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IRS1—obesity	9.93e-06	0.000107	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—INS—obesity	9.93e-06	0.000107	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOB—obesity	9.75e-06	0.000106	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—POMC—obesity	9.57e-06	0.000103	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—INS—obesity	9.51e-06	0.000103	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL2—obesity	9.36e-06	0.000101	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPL—obesity	9.31e-06	0.000101	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CD—obesity	9.22e-06	9.97e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—obesity	9.2e-06	9.95e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT2—obesity	9.19e-06	9.95e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—obesity	9.1e-06	9.85e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX1—obesity	9.09e-06	9.83e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CD36—obesity	8.85e-06	9.57e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CD—obesity	8.83e-06	9.56e-05	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CA—obesity	8.75e-06	9.47e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SERPINE1—obesity	8.74e-06	9.45e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3R1—obesity	8.71e-06	9.42e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—obesity	8.71e-06	9.42e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TYK2—obesity	8.5e-06	9.19e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RHOA—obesity	8.43e-06	9.12e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—obesity	8.39e-06	9.07e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3R1—obesity	8.34e-06	9.02e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—obesity	8.34e-06	9.02e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARA—obesity	8.23e-06	8.9e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CB—obesity	8.04e-06	8.69e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AGT—obesity	7.97e-06	8.62e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—obesity	7.96e-06	8.61e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CA—obesity	7.95e-06	8.6e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOE—obesity	7.81e-06	8.45e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAV1—obesity	7.73e-06	8.37e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA1—obesity	7.72e-06	8.35e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MTOR—obesity	7.7e-06	8.33e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CB—obesity	7.7e-06	8.33e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.39e-06	7.99e-05	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—obesity	7.15e-06	7.73e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CG—obesity	7.05e-06	7.62e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—obesity	7.04e-06	7.61e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARG—obesity	6.8e-06	7.36e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—POMC—obesity	6.71e-06	7.26e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—obesity	6.69e-06	7.24e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—INS—obesity	6.67e-06	7.22e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK8—obesity	6.51e-06	7.04e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—obesity	6.49e-06	7.02e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CD—obesity	6.19e-06	6.7e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—obesity	6.11e-06	6.61e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT3—obesity	5.95e-06	6.44e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3R1—obesity	5.85e-06	6.33e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—obesity	5.85e-06	6.33e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MYC—obesity	5.53e-06	5.98e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—obesity	5.52e-06	5.97e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CB—obesity	5.4e-06	5.84e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—obesity	5.35e-06	5.79e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CA—obesity	4.9e-06	5.3e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CA—obesity	4.69e-06	5.08e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—obesity	4.16e-06	4.5e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—obesity	4e-06	4.33e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—obesity	3.83e-06	4.15e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CA—obesity	3.29e-06	3.56e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—obesity	2.69e-06	2.91e-05	CbGpPWpGaD
